Hamlet BioPharma raises SEK 25.7 million from warrant exercise, issues 4,283,006 B shares
Reuters2026/08/05 14:38- Hamlet Biopharma raised a preliminary SEK 25.7 million from the exercise of TO5B warrants.
- Subscriptions covered 4,283,006 new B shares at SEK 6 per share; the preliminary exercise rate was about 79%.
- One transaction for 301,048 TO5B warrants remains unfinished for administrative reasons, covering SEK 1.81 million.
- If completed, the total proceeds would remain SEK 25.7 million before issue costs; total B shares would be 150,552,055.
- TO6B warrants outstanding total 6,976,744; exercise window runs Jan. 17–31, 2028 at SEK 10 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"Expensive Protection" Arbitrage Opportunities in a Calm US Stock Market: SocGen Recommends Selling Short-Term Tail Volatility, but Hedging Against Crash Risks
Société Générale stated that the surge in short-term S&P 500 option premiums is creating attractive opportunities for selling volatility strategies, but it is necessary to hedge against downside risk.
BUUU Group signs deal to buy 60% stake in modular data center provider Brightray Science
Goldman Sachs remains bullish on the South Korean stock market: Driven by the AI memory boom, with a potential upside of up to 80%.
Goldman Sachs strategist Timothy Moe maintains his bullish target on the South Korean stock market, believing that investors are underestimating how long the benefits of artificial intelligence (AI) will last for the country's memory chip manufacturers.
Crypto prices
More
